The FDA warns that comfrey contains pyrrolizidine alkaloids that can cause cirrhosis and liver failure when taken orally in high doses.

Topical application is safer and more effective; allantoin in comfrey stimulates cell proliferation, accelerating wound healing.

Oral products containing comfrey are banned in the USA, UK, Australia, Canada and Germany.